Skip to main content
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · S2P ISIN · HK0000658531 HKEX Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2024-11-01 Transaction in Own Shar…
Country CN China
Listing HKEX S2P

About Simcere Pharmaceutical Group Limited

https://www.simcere.com/en/

Simcere Pharmaceutical Group Limited is an R&D-driven pharmaceutical company specializing in the discovery, development, and commercialization of innovative and branded generic prescription drugs. The company strategically focuses on core therapeutic areas, including neuroscience, anti-oncology, and inflammatory diseases. Simcere emphasizes synergistic innovation, evidenced by its development and launch of multiple Category I innovative pharmaceuticals and its strategic collaborations with global partners to advance novel treatments. These partnerships aim to address significant unmet medical needs and expand the company's portfolio across specialized disease areas.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a detailed disclosure return related to changes in issued shares and treasury shares, including share buybacks and repurchases. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, prices, and dates. The document is not a financial report like an annual or interim report, nor is it a simple announcement. It is a regulatory disclosure specifically about share repurchases and changes in capital structure. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2024-11-01 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares or treasury shares, including share buybacks and repurchases. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share capital changes. The content includes detailed tables of shares repurchased, dates, prices, and confirmations of compliance with listing rules. There is no indication of financial performance data, earnings, management discussion, or other report types. The document is a regulatory disclosure about share repurchases and changes in capital structure. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the correct classification is POS with high confidence.
2024-10-31 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and details share repurchase transactions with dates, prices, and quantities. The content is focused on reporting share repurchase activity and changes in share capital rather than financial results, management changes, or other corporate events. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback or sale of its own shares. The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-10-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share repurchases and changes in issued shares. The content includes detailed tables of shares repurchased, dates, prices, and confirmations of compliance with listing rules. There is no indication of financial statements, earnings data, management discussion, or other report types. The document is a regulatory disclosure about share repurchase activity and changes in capital structure, fitting the category of a Transaction in Own Shares report.
2024-10-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and repurchases. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) concerning disclosure of share repurchases and changes in issued shares. The content includes detailed tables of shares repurchased, prices, dates, and confirmations of compliance with listing rules. This is a regulatory disclosure about share repurchase activity and changes in capital structure, not a financial report or earnings release. It fits the category of a company announcement regarding share repurchase or capital changes. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a full disclosure report on share repurchases.
2024-10-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a detailed disclosure return related to changes in issued shares and treasury shares, including share buybacks and repurchases. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed tables of share repurchase transactions, prices, and dates. The content focuses on share repurchase activities and changes in capital structure rather than financial results, management changes, or regulatory certifications. The document length is substantial (15,000 characters) and contains substantive data on share repurchases and issued shares changes. This matches the definition of a Transaction in Own Shares (POS) filing, which reports the company's buyback or sale of its own shares.
2024-10-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.